drugset / Trial / NCT01024660

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

NCT01024660

Phase 0 Completed 155 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to determine if there is improvement or measurable change in cognition after only one month of treatment with donepezil when using a computerized test battery. The results at one month will be compared with the results at 3 months to evaluate this.

Timeline

Start
2009-12
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Donepezil Small molecule 10 mg Oral

Indications